Amprenavir

Amprenavir

SCHEMBL10276771

CC(C)CN(CC(O)C(Cc1ccccc1)NC(=O)O[C@@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

pol

The experimentally established mechanism targets of Amprenavir. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 1.00
ABCB11 O95342 1/20 1.00
LMNA P02545 1/20 1.00
CTSD P07339 1/20 1.00
CYP3A4 P08684 1/20 1.00
CYP3A5 P20815 1/20 1.00
CNR1 P21554 1/20 1.00
TBXAS1 P24557 1/20 1.00
ADRA1A P35348 1/20 1.00
ABCB1 P08183 1/20 0.72
KCNE1 P15382 1/20 0.72
KCNQ1 P51787 1/20 0.72
KCNH2 Q12809 1/20 0.72
SCN5A Q14524 1/20 0.72
KCND3 Q9UK17 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amprenavir SCHEMBL7287657 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL11914014 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL1388821 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL20099148 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL5551513 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL3174937 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL34151 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL2671137 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL20451345 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4
Amprenavir SCHEMBL12647024 1.00 MLNR (1.00) MLNRABCB11LMNACTSDCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012046062-A1 USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS SHIRE, LLC (US) 2012-04-12 WO disclosed